Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Aytu Biopharma (AYTU) Tax Provisions: 2014-2025

Historic Tax Provisions for Aytu Biopharma (AYTU) over the last 1 years, with Jun 2025 value amounting to $652,000.

  • Aytu Biopharma's Tax Provisions fell 22.47% to $652,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $635,000, marking a year-over-year decrease of 72.25%. This contributed to the annual value of $652,000 for FY2025, which is 69.56% down from last year.
  • Aytu Biopharma's Tax Provisions amounted to $652,000 in Q2 2025, which was up 634.43% from -$122,000 recorded in Q1 2025.
  • Over the past 5 years, Aytu Biopharma's Tax Provisions peaked at $841,000 during Q2 2024, and registered a low of -$300,000 during Q4 2024.
  • Over the past 3 years, Aytu Biopharma's median Tax Provisions value was $463,000 (recorded in 2024), while the average stood at $365,375.
  • The largest annual percentage gain for Aytu Biopharma's Tax Provisions in the last 5 years was 567.46% (2024), contrasted with its biggest fall of 137.50% (2024).
  • Over the past 4 years, Aytu Biopharma's Tax Provisions (Quarterly) stood at -$3,000 in 2021, then reached $800,000 in 2023, then slumped by 137.50% to -$300,000 in 2024, then fell by 22.47% to $652,000 in 2025.
  • Its Tax Provisions stands at $652,000 for Q2 2025, versus -$122,000 for Q1 2025 and -$300,000 for Q4 2024.